文献与产业新闻· Nature Medicine·· 2026-08-25评分10
Survodutide SYNCHRONIZE-MASLD 三期论文发表作者更正
Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial
导读
Nature Medicine 发表对 Survodutide SYNCHRONIZE-MASLD 三期随机双盲安慰剂对照试验论文的作者更正。该原始研究在伴肥胖的代谢功能障碍相关脂肪性肝病（MASLD）成人中评估 Survodutide。
来源：文献与产业新闻 · nature.com